ICER & net benefit
Compare two options on cost and QALYs. Read the ICER, place the result on the cost-effectiveness plane, and see how net benefit gives a cleaner verdict against a threshold you set.
ΔCost
—
ΔEffect
—
ICER (per QALY)
—
Net monetary benefit
—
Net health benefit
—
Shaded band: NICE's £25,000–£35,000 reference range. Marker: an empirical opportunity-cost estimate, ≈£13,000.
Enter both options to see the comparison.
Notice the ICER alone can't tell you which way to read it — the same £/QALY means opposite things in the top-right and bottom-left. Net benefit carries the sign, so one rule (NMB > 0 = adopt) works in every quadrant.
Cost-effectiveness plane
The same ICER can sit above the line in one quadrant and below it in another — position, not just the ratio, decides.
Net benefit vs threshold
Net benefit is linear in the threshold. Where it crosses zero is the ICER — below and above it the verdict flips. In a dominant/dominated case the line never crosses zero.